National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

laromustine
A sulfonyl hydrazine prodrug with antineoplastic activity. Laromustine releases the DNA chloroethylating agent 90CE after entering the blood stream; 90CE chloroethylates alkylates the 06 position of guanine, resulting in DNA crosslinking, strand breaks, chromosomal aberrations, and disruption of DNA synthesis. Intracellular metabolism of this agent also releases methyl isocyanate which inhibits 06-alkyl-guanine transferase, an enzyme involved with DNA repair. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:Cloretazine
Onrigin
Code name:VNP40101M
Chemical structure names:
  • 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine
  • 2'-(2-chloroethyl)-N-methyl-1',2'-bis(methylsulfonyl)carbamohydrazide
  • methanesulfonic acid, 1-(2-chloroethyl)-2-[(methylamino)carbonyl]-2- (methylsulfonyl)hydrazide



Previous:Lanreotide Autogel, lanreotide long-acting aqueous gel, lapatinib ditosylate, Laradopa, Larodopa
Next:larotaxel, Lasix, Laudicon, leflunomide, lenalidomide

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov